SCHEMBL1129948

SCHEMBL1129948

O=C(Nc1ccc(O)c(C(=O)O)c1)c1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.77
PKM P14618 3/20 0.77
SIRT6 Q8N6T7 2/20 0.67
MEN1 O00255 3/20 0.64
SIRT3 Q9NTG7 1/20 0.64
MAPT P10636 4/20 0.61
KDM4E B2RXH2 2/20 0.61
ALOX15 P16050 1/20 0.61
ALDH1A1 P00352 1/20 0.61
KCNK3 O14649 1/20 0.61
KCNK9 Q9NPC2 1/20 0.61
AKR1C3 P42330 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
MAPK1 P28482 1/20 0.57
POLB P06746 1/20 0.57
TSHR P16473 1/20 0.57
HSD17B10 Q99714 1/20 0.57
AKR1C2 P52895 1/20 0.57
AKR1C1 Q04828 1/20 0.57
NPC1 O15118 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10758235 0.91 SIRT6 (0.64) KMT2APKMSIRT6MEN1SIRT3
SCHEMBL13805528 0.89 SIRT6 (0.65) KMT2APKMSIRT6MEN1SIRT3
SCHEMBL6346820 0.89 KMT2A (0.65) KMT2APKMSIRT6MEN1MAPT
SCHEMBL10763914 0.87 KMT2A (0.69) KMT2APKMMEN1MAPTKDM4E
Benzoylpas SCHEMBL563122 0.87 KMT2A (1.00) KMT2APKMSIRT6MEN1MAPT
SCHEMBL11593167 0.86 KMT2A (0.76) KMT2APKMMEN1MAPTKDM4E
SCHEMBL7553405 0.86 KMT2A (0.61) KMT2APKMSIRT6MEN1SIRT3
SCHEMBL10759208 0.86 MITF (0.64) KMT2APKMSIRT6MEN1SIRT3
SCHEMBL23796858 0.85 SIRT6 (0.58) KMT2APKMSIRT6MEN1SIRT3
SCHEMBL30418835 0.85 SIRT6 (0.58) KMT2APKMSIRT6MEN1SIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0236329-A1 AMINO-SALICYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ITAL-FARMACO S.p.A. (IT) 1987-09-16 EP claimed
WO-1986003199-A1 AMINO-SALICYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ITALFARMACO S.P.A. (IT) 1986-06-05 WO claimed
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
US-8283287-B2 Thermosensitive recording material RICOH COMPANY, LTD. (JP) 2012-10-09 US disclosed
EP-2036737-B1 Thermosensitive recording material RICOH CO LTD (JP) 2011-02-16 EP disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
US-20090075817-A1 THERMOSENSITIVE RECORDING MATERIAL RICOH COMPANY, LTD. (JP) 2009-03-19 US disclosed
EP-2036737-A1 Thermosensitive recording material Ricoh Company, Ltd. (JP) 2009-03-18 EP disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC KMT2A 998/4885PKM 3215/4885SIRT6 3550/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR KMT2A 847/4885PKM 531/4885SIRT6 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.